EUVIMEDScopri EUVIMED
Crossref

Pre‐transplant multidrug‐resistant infections in liver transplant recipients‐epidemiology and impact on transplantation outcome

Gabriela T Lemos, Debora R B Terrabuio, Nathalia N Nunes iD, Alice T W Song, Isabel C V Oshiro, Luiz Augusto C D'Albuquerque, Anna S Levin, Edson Abdala, Maristela P Freire iD

Clinical Transplantation · 2024-01 · 38 (1)

DOI: 10.1111/ctr.15173 ↗

At a glance

Journal article in Clinical Transplantation, published online on 2023-10-25. Written by Gabriela T Lemos and 8 co-authors. Institution: Department of Infectious Diseases, University of São Paulo School of Medicine Hospital das Clínicas, Sao Paulo, Brazil. Major MEDLINE topics: Liver Transplantation, Carcinoma, Hepatocellular, Liver Neoplasms, Bacterial Infections. Cited 14 times so far (Crossref); 34 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Cirrhotic patients are highly exposed to healthcare services and antibiotics. Although pre‐liver transplantation (LT) infections are directly related to the worsening of liver function, the impact of these infections on LT outcomes is still unclear. This study aimed to identify the effect of multidrug‐resistant microorganism (MDRO) infections before LT on survival after LT.

Methods

Retrospective study that included patients who underwent LT between 2010 and 2019. Variables analyzed were related to patients’ comorbidities, underlying diseases, time on the waiting list, antibiotic use, LT surgery, and occurrences post‐LT. Multivariate analyses were performed using logistic regression, and Cox regression for survival analysis.

Results

A total of 865 patients were included; 351 infections were identified in 259 (30%) patients, of whom 75 (29%) had ≥1 pre‐LT MDRO infection. The most common infection was spontaneous bacterial peritonitis (34%). The agent was identified in 249(71%), 53(15%) were polymicrobial. The most common microorganism was Klebsiella pneumoniae (18%); the most common MDRO was ESBL‐producing Enterobacterales (16%), and carbapenem‐resistant (CR) Enterobacterales (10%). Factors associated with MDRO infections before LT were previous use of therapeutic cephalosporin ( p = .001) and fluoroquinolone ( p = .001), SBP prophylaxis ( p = .03), ACLF before LT ( p = .03), and days of hospital stay pre‐LT ( p < .001); HCC diagnosis was protective ( p = .01). Factors associated with 90‐day mortality after LT were higher MELD on inclusion to the waiting list ( p = .02), pre‐LT MDRO infection ( p = .04), dialysis after LT ( p < .001), prolonged duration of LT surgery ( p < .001), post‐LT CR‐Gram‐negative bacteria infection ( p < .001), and early retransplantation ( p = .004).

Conclusion

MDRO infections before LT have an important impact on survival after LT.

Subjects

MeSH terms (MEDLINE)

Liver TransplantationCarcinoma, HepatocellularLiver NeoplasmsBacterial InfectionsCommunicable DiseasesHumansRetrospective StudiesRisk FactorsAnti-Bacterial AgentsPostoperative Complications

Author keywords

ESBL-producingEnterobacteralescarbapenem resistancedialysismeldmortalityretransplantationrisk factors

Substances

Anti-Bacterial Agents

Authors and institutions

  • Department of Infectious Diseases, University of São Paulo School of Medicine Hospital das Clínicas, Sao Paulo, Brazil.
  • Division of Clinical Gastroenterology and Hepatology, Hospital das Clínicas, Department of Gastroenterology of University of São Paulo School of Medicine, Sao Paulo, Brazil.
  • Division of Liver and Gastrointestinal Transplant, Hospital das Clínicas, Department of Surgery, University of São Paulo School of Medicine, Sao Paulo, Brazil.
  • Working Committee for Hospital Epidemiology and Infection Control, University of São Paulo School of Medicine Hospital das Clínicas, Sao Paulo, Brazil.

ORCID profiles: Nathalia N Nunes, Maristela P Freire

Cite

APA

Lemos, G. T., Terrabuio, D. R. B., Nunes, N. N., Song, A. T. W., Oshiro, I. C. V., D'Albuquerque, L. A. C., Levin, A. S., Abdala, E., & Freire, M. P. (2024). Pre‐transplant multidrug‐resistant infections in liver transplant recipients‐epidemiology and impact on transplantation outcome. Clinical Transplantation, 38(1). https://doi.org/10.1111/ctr.15173

Vancouver

Lemos GT, Terrabuio DRB, Nunes NN, Song ATW, Oshiro ICV, D'Albuquerque LAC, et al. Pre‐transplant multidrug‐resistant infections in liver transplant recipients‐epidemiology and impact on transplantation outcome. Clinical Transplantation. 2024;38(1). doi:10.1111/ctr.15173

BibTeX
@article{Lemos2024,
  author = {Lemos, Gabriela T and Terrabuio, Debora R B and Nunes, Nathalia N and Song, Alice T W and Oshiro, Isabel C V and D'Albuquerque, Luiz Augusto C and Levin, Anna S and Abdala, Edson and Freire, Maristela P},
  title = {Pre‐transplant multidrug‐resistant infections in liver transplant recipients‐epidemiology and impact on transplantation outcome},
  journal = {Clinical Transplantation},
  year = {2024},
  volume = {38},
  number = {1},
  doi = {10.1111/ctr.15173}
}
Start for free →